Annual Operating Expenses
$167.69 M
+$59.98 M+55.69%
31 December 2023
Summary:
Keros Therapeutics annual total operating expenses is currently $167.69 million, with the most recent change of +$59.98 million (+55.69%) on 31 December 2023. During the last 3 years, it has risen by +$123.50 million (+279.42%). KROS annual operating expenses is now at all-time high.KROS Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Expenses
$59.05 M
+$8.57 M+16.98%
30 September 2024
Summary:
Keros Therapeutics quarterly total operating expenses is currently $59.05 million, with the most recent change of +$8.57 million (+16.98%) on 30 September 2024. Over the past year, it has increased by +$15.76 million (+36.40%). KROS quarterly operating expenses is now at all-time high.KROS Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
KROS Operating Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +55.7% | +36.4% |
| 3 y3 years | +279.4% | +192.3% |
| 5 y5 years | +1381.3% | +1123.5% |
KROS Operating Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +279.4% | at high | +192.3% |
| 5 y | 5 years | at high | +1381.3% | at high | +1123.5% |
| alltime | all time | at high | +1381.3% | at high | +1137.1% |
Keros Therapeutics Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $59.05 M(+17.0%) |
| June 2024 | - | $50.48 M(+3.9%) |
| Mar 2024 | - | $48.57 M(+9.9%) |
| Dec 2023 | $167.69 M(+55.7%) | $44.20 M(+2.1%) |
| Sept 2023 | - | $43.29 M(+4.7%) |
| June 2023 | - | $41.34 M(+6.3%) |
| Mar 2023 | - | $38.87 M(+21.6%) |
| Dec 2022 | $107.71 M(+40.8%) | $31.96 M(+31.7%) |
| Sept 2022 | - | $24.27 M(-11.3%) |
| June 2022 | - | $27.35 M(+13.4%) |
| Mar 2022 | - | $24.13 M(-3.0%) |
| Dec 2021 | $76.47 M | $24.87 M(+23.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2021 | - | $20.20 M(+29.1%) |
| June 2021 | - | $15.64 M(-0.8%) |
| Mar 2021 | - | $15.77 M(+45.6%) |
| Dec 2020 | $44.20 M(+120.9%) | $10.83 M(-9.3%) |
| Sept 2020 | - | $11.95 M(+9.5%) |
| June 2020 | - | $10.91 M(+3.9%) |
| Mar 2020 | - | $10.50 M(+100.9%) |
| Dec 2019 | $20.00 M(+76.7%) | $5.23 M(+8.3%) |
| Sept 2019 | - | $4.83 M(+1.1%) |
| June 2019 | - | $4.77 M(-7.8%) |
| Mar 2019 | - | $5.18 M |
| Dec 2018 | $11.32 M | - |
FAQ
- What is Keros Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for Keros Therapeutics?
- What is Keros Therapeutics annual operating expenses year-on-year change?
- What is Keros Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Keros Therapeutics?
- What is Keros Therapeutics quarterly operating expenses year-on-year change?
What is Keros Therapeutics annual total operating expenses?
The current annual operating expenses of KROS is $167.69 M
What is the all time high annual operating expenses for Keros Therapeutics?
Keros Therapeutics all-time high annual total operating expenses is $167.69 M
What is Keros Therapeutics annual operating expenses year-on-year change?
Over the past year, KROS annual total operating expenses has changed by +$59.98 M (+55.69%)
What is Keros Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of KROS is $59.05 M
What is the all time high quarterly operating expenses for Keros Therapeutics?
Keros Therapeutics all-time high quarterly total operating expenses is $59.05 M
What is Keros Therapeutics quarterly operating expenses year-on-year change?
Over the past year, KROS quarterly total operating expenses has changed by +$15.76 M (+36.40%)